Profile
| Metric | Value |
|---|---|
| Full Name | Johnson & Johnson |
| Ticker | NYSE: JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | jnj.com |
| Employees | 138,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $227.25 | |
| Price, 1D Change | -0.02% | |
| Market Cap | $548B | |
| TTM Dividend Yield | 2.26% | |
| PE Ratio | 20.57 | |
| Beta | 0.07 | |
| Revenue | $94B | |
| Revenue, 1Y Change | +6.05% | |
| EPS | $11.03 | |
| EPS, 1Y Change | +90.56% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.30 | |
| Next Ex-Dividend | $1.30 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $11.03 | |
| EPS Estimate | N/A | $11.53 |
| EPS Est. Change | N/A | +4.54% |
| Revenue | $94.19B | |
| Revenue Estimate | N/A | $100.61B |
| Revenue Est. Change | N/A | +6.82% |
| Current Price | $227.25 | |
| Price Target | - | $228.50 |
| Price Tgt. Change | - | +0.55% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.96 | $5.79 | -41.85% | |
| $10.81 | $11.03 | +2.08% | |
| $11.53 | N/A | +4.54% | |
| $12.49 | N/A | +13.20% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $88.78B | $88.82B | +0.05% | |
| $93.76B | $94.19B | +0.46% | |
| $100.61B | N/A | +6.82% | |
| $105.30B | N/A | +11.80% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +48.66% | |
| Price, 3Y | +40.28% | |
| Market Cap, 1Y | +48.80% | |
| Market Cap, 3Y | +29.31% | |
| Revenue, 1Y | +6.05% | |
| Revenue, 3Y | +17.65% | |
| EPS, 1Y | +90.56% | |
| EPS, 3Y | +63.82% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $227.25 | |
| SMA 200 | $179.70 | |
| SMA 200 vs Price | -20.92% | |
| SMA 50 | $210.05 | |
| SMA 50 vs Price | -7.57% | |
| Beta | 0.07 | |
| ATR | $3.78 | |
| 14-Day RSI | 77.18 | |
| 10-Day Volatility | 10.52% | |
| 1-Year Volatility | 19.02% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.30 | |
| Upcoming | $1.30 | |
| Dividend Yield | 2.26% | |
| Total Dividend | $5.14 | |
| Dividends Paid | - | |
| Payout Ratio | - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $94.19B | |
| EPS | $11.03 | |
| Gross Profit | $68.56B | |
| Gross Margin | 72.78% | |
| Operating Profit | $25.60B | |
| Operating Margin | 27.17% | |
| Net Income | $26.80B | |
| Net Margin | 28.46% | |
| EBITDA | - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | - | |
| Current Ratio | - | |
| Quick Ratio | - | |
| - | ||
| F-Score | - | |
| Altman Z-Score | - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 20.57 | |
| PS Ratio | 5.81 | |
| PB Ratio | - | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | - | |
| Cash & Equivalents | - | |
| Total Assets | - | |
| Current Assets | - | |
| Total Liabilities | - | |
| Current Liabilities | - | |
| Total Debt | $0.00 | |
| Short Term Debt | - | |
| Accounts Payable | - |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $67.39B | |
| Operating Expenses | $42.96B | |
| Cost Of Goods Sold | $25.64B | |
| SG&A | $0.00 | |
| D&A | - | |
| Interest Expense | $0.00 | |
| Income Tax | $5.78B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | - | |
| CFI | - | |
| CFF | - | |
| Capex | - | |
| Free Cash Flow | - |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Wells Fargo | → | |
| TD Cowen | → | |
| Stifel | → | |
| Scotiabank | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| B of A Securities | → | |
| Bernstein | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with JNJ
FAQ
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is NYSE:JNJ
Does Johnson & Johnson pay dividends?
Yes, Johnson & Johnson pays dividends. The last payment was $1.30, with an ex-dividend date on November 25, 2025
What sector is Johnson & Johnson in?
Johnson & Johnson is in the Healthcare sector
What industry is Johnson & Johnson in?
Johnson & Johnson is in the General Drug Manufacturers industry
What country is Johnson & Johnson based in?
Johnson & Johnson is headquartered in United States
When did Johnson & Johnson go public?
Johnson & Johnson initial public offering (IPO) was on January 2, 1943
Is Johnson & Johnson in the S&P 500?
Yes, Johnson & Johnson is included in the S&P 500 index
Is Johnson & Johnson in the NASDAQ 100?
No, Johnson & Johnson is not included in the NASDAQ 100 index
Is Johnson & Johnson in the Dow Jones?
Yes, Johnson & Johnson is included in the Dow Jones index
When was Johnson & Johnson last earnings report?
Johnson & Johnson's most recent earnings report was on January 21, 2026
When does Johnson & Johnson report earnings?
The next expected earnings date for Johnson & Johnson is April 14, 2026
Data Sources & References
- JNJ Official Website www.jnj.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of Dow Jones Industrial Average Companies en.wikipedia.org/wiki/Dow_Jones_Industrial_Average
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj
